Fecal Calprotectin Can Predict Relapse in Inflammatory Bowel Disease Patients in Endoscopic Remission: A Plea for Extreme Deep Remission?

被引：0
|
作者：
Mooiweer, Erik
Severs, Mirjam
Schipper, Marguerite E.
Fidder, Herma
Siersema, Peter D.
Laheij, Robert
Oldenburg, Bas
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1215
引用
收藏
页码：S233 / S233
页数：1
相关论文
共 50 条
  • [31] Accuracy of fecal calprotectin predicting endoscopic activity in Inflammatory Bowel Disease patients
    Jusue, V.
    Chaparro, M.
    Gisbert, J. P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S194 - S194
  • [32] Proactive infliximab is more effective than vedolizumab in inducing fecal calprotectin remission in inflammatory bowel disease
    Fernandes, Samuel Raimundo
    Rodrigues, Ines Coelho
    Serrazina, Juliana
    Botto, Ines Ayala
    Bernardo, Sonia
    Goncalves, Ana Rita
    Valente, Ana
    Santos, Paula Moura
    Correia, Luis Araujo
    Marinho, Rui Tato
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (10) : 1202 - 1208
  • [33] Accuracy of fecal calprotectin in the prediction of endoscopic activity in inflammatory bowel disease patients
    Jusue, V.
    Chaparro, M.
    Gisbert, J. P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S183 - S183
  • [34] Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
    Walkiewicz, Dorota
    Werlin, Steven L.
    Fish, Daryl
    Scanlon, Mathew
    Hanaway, Patrick
    Kugathasan, Subra
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (05) : 669 - 673
  • [35] Fecal leukocyte esterase level can predict endoscopic activity for Inflammatory Bowel Disease patients
    Weng, M. T.
    Tsai, F. P.
    Tung, C. C.
    Wu, H. Y.
    Chen, Z. C.
    Wei, S. C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I652 - I652
  • [36] Can vitamin D induce remission in patients with inflammatory bowel disease?
    Goulart, Ricardo de Alvares
    Barbalho, Sandra Maria
    [J]. ANNALS OF GASTROENTEROLOGY, 2022, 35 (02): : 140 - 149
  • [37] Irritable Bowel Syndrome on Inflammatory Bowel Disease in Deep Remission: No Relation with Remission Deepening and Inflammation
    Sezgin, Orhan
    Boztepe, Burcu
    Ucbilek, Enver
    Altintas, Engin
    Celikcan, Havva Didem
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (10): : 870 - 878
  • [38] Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission
    Diederen, K.
    Hoekman, D. R.
    Leek, A.
    Wolters, V. M.
    Hummel, T. Z.
    de Meij, T. G.
    Koot, B. G. P.
    Tabbers, M. M.
    Benninga, M. A.
    Kindermann, A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (07) : 951 - 960
  • [39] Adalimumab in Crohn's Disease Patients to Maintain Surgically-induced Remission: Can Fecal Calprotectin Predict Postoperative Recurrence?
    Fdez-Blanco, Ignacio
    Martinez, Barbara
    Codoceo, Rosa
    Maria Monturiol, Jose
    Garcia-Montes, Miguel
    Cara, Carlos
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S467 - S467
  • [40] Adalimumab in Crohn's Disease patients to maintain surgically-induced remission: Can fecal calprotectin predict postoperative recurrence?
    Fernandez-Blanco, I
    Martinez, B.
    Codoceo, R.
    Monturiol, J.
    Garcia-Montes, M.
    Cara, C.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S40 - S41
12345